Moderators: Concepción Gómez-Gavara & Silvio Nadalin

• Intraoperative Assessment of Portal Vein Arterialization: A Review of Heterogeneous Practices and Proposal for Standardized Flow Evaluation - Federico Lozio
• Artificial intelligence-assisted intraoperative navigation for safe right liver mobilization in pure laparoscopic donor hepatectomy: an experimental multi-institutional validation study - Inho Lee
• Graft-to-Recipient Weight Ratio, Graft Inflow Modulation, and Small-for-Size Syndrome: Insights from the International Living Donor Liver Transplant Registry (LDLTregistry.org) - Dieter Broering
• Circulating Tumor DNA in Liver Transplantation for Unresectable Colorectal Liver Metastasis - Abigail Loszko
• R0N0 resection for perihilar cholangiocarcinoma offers survival similar to transplantation: A multicentre pan-European study - Aarathi Vijayashanker

Q&A

Moderators: Parissa Tabrizian & Eric Vibert

• Results of the Initial Cases from the International Ex Situ Liver Surgery Database - Alejandro Serrablo
• ALPPS for CRLM: risk analysis for early recurrence - Jun Li
• Evolving Patterns of Adjuvant Chemotherapy And Survival After Surgery For Peri-hilar Cholangiocarcinoma: Results From The UK Nationwide Capbil Study -  Aarathi Vijayashanker
• Prognosis of associating liver partition and portal vein ligation for staged hepatectomy to treat patients with hepatocellular carcinoma - Yiming Zhao
• A Novel Bioengineered Pancreatojejunostomy to Prevent Postoperative Fistula: Ex Vivo and In Vivo Evaluation of the PJ-Ring Device - Graziano Oldani

Q&A

Moderator: Karim Halazun & Parissa Tabrizian

• Liver Navigation and use of ICG in HCC liver surgery - Eric Vibert 
• AI to diagnose and stage HCC on imaging – Are we there yet? Xioyang Liu
• Advanced liver surgery for HCC with the use of intraoperative navigation techniques - Jiri Fronek
• Predicting outcomes of HCC resection and transplant using AI - Guido Torzilli

Q&A

Moderator: Prashant Bhangui & Maria Bernadette Doyle

• Case 1: Resectable HCC in Child B cirrhosis (East vs West experience) - Andrea Ruzzenente & Alfred Kow
• Case 2: Advanced HCC with vascular involvement successfully down-staged to resection with Immuno/IR/SBRT (Neoadjuvant) - Sang-Hoon Kim
• Case 3: Advanced HCC Neoadjuvant Immuno to Tx - Parissa Tabrizian

Panel: Robert Lewandowski, Krishna Menon, Silvio Nadalin, Erica Tsang

Moderator: Deniz Balci & Roberto Hernandez-Alejandro

• Liver Regeneration and Hepatectomy: Where are we in 2025 - Shintaro Yagi
• Two-Stage Hepatectomy and Modulation of Future Liver Remnant: Status Quo 2025 - Henrik Petrowsky
• Two-Stage Liver Transplantation: APOLT, RAPID update: Status Quo 2025 - Umberto Cillo

Q&A

Moderator: Albert Chan & Claire Goumard

• Surgical Strategies: Resection as a Viable DS strategy in giant and multifocal HCC (Intermediate Stage) - Dong-Sik Kim
• The Transplantation Paradigm: Where do we draw the line? Expanding Role and Considerations - Christian Toso
• Optimizing Treatment Pathways: Neoadjuvant Approaches in Intermediate Stage HCC: upfront vs LRT vs systemic vs combo approaches - Should u do systemic as neoadjuvant and then surgery - Umut Demirci

Q&A

Moderator: Chul-Soo Ahn & Shintaro Yagi

• Curative Approaches to;
  • Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - Transplant - Prashant Bhangui
  • Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - Surgery - Shimul Shah
  • Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - IR - Robert Lewandowski
  • Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - SBRT - Laura Dawson
• Alpha-fetoprotein and Beyond: Biomarkers in HCC Diagnosis and Prognosis - Augusto Villanueva
• Predicting Treatment Response: Biomarker Signatures in Surgery, Immunotherapy and Beyond - Krishna Menon

Q&A

Moderators: Elvan Onur Kirimker & Blayne Amir Sayed

• Novel Approach to Viability Assessment of Split Liver Grafts Using Hypothermic Oxygenated Perfusion - Geofia Crasta
• Promoting Microsurgical Competence in arterial reconstruction for Living-Donor Liver Transplantation: A Hands-On Training Model by the ISEM Japan Chapter - Shintaro Yagi
• Parenchymal-Sparing One-Stage Hepatectomy Matches Liver Transplantation Survival In Bilobar Colorectal Liver Metastases: Toward A Refinement Of Transplant Candidacy - Flavio Milana
• Liver Transplantation Using Split Or Reduced Liver Grafts – Czech Experience With 289 Consecutive Cases - Marek Kysela
• Impact of Intravenous Somatostatin on LDLT Right Lobe Donor Outcomes - Emre Aray

Q&A

Moderators: Dieter Broering & Yee Lee Cheah

• Total Robotic Liver Transplant: Early Experience and Short-term Outcomes - Diego Chaparro Zaraza
• A Randomized Controlled Trial Of Resection Versus Thermal Ablation Of Colorectal Cancer Liver Metastases (New Comet) - Ingrid Schrøder Hansen
• 1,000 Robotic Operations: Establishing Standards for the Safe Integration of Robotic Innovation in Transplant Surgery - Diego Chaparro Zaraza

Q&A

Moderators: Marieke De Boer & Alfred Wei Chieh Kow

• Resection for locally advanced iCCA, including vascular resections and ALPP - Silvio Nadalin
• How effective can be a downstaging therapy? - Jun Li
• Incorporating genomic and directed therapies into the management of intrahepatic cholangiocarcinoma - Robert Grant

Q&A

Moderator: Olivier Scatton

• Vascular Resections and Value of Lymphadenectomies in hCCA - Alejandro Serrablo
• Optimization of Future Liver Remnant in patients with hCCA - Felix Oldhafer 
• Liver Transplantation for hCCA - Nicolas Goldaracena

Q&A

State of the Art Lecture: LT for HCC - Where are we in 2025? And what the future holds.
Speaker: Karim Halazun
Q&A Session moderated by Gonzalo Sapisochin & Myron Schwartz

Moderators: Elizabeth Pando & Orlando Torres

• Biological vs technical resectability - Güralp Onur Ceyhan
• Therapeutic approach for borderline tumors - Shailesh Shrikhande
• In the era of robotic surgery: Is laparoscopic Whipple dead? - David Kooby

Q&A

Moderators: Robert Grant

• PRO: Neoadjuvant Therapy for Resectable Pancreas Cancer - Matthew Katz
• CON: Neoadjuvant Therapy for Resectable Pancreas Cancer - Henrik Petrowsky

Q&A

Moderators: Paul Karanicolas & Chaya Shwaartz 

• Predicting The Best Potential Treatment By Artificial Intelligence For Patients Affected By Hepatocellular Carcinoma: Development Of A Tailored Model On Real-World Big Data - Simone Famularo
• Neoadjuvant Treatment Followed by Surgery Versus Upfront Surgery for Intrahepatic Cholangiocarcinoma: An International Multicenter Cohort Study - Anudari Zorigtbaatar
• Ten-year experience review - pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability - Yi Pang Brian Liu
• Liver Resection For Ovarian Cancer Liver Metastases: Survival Comparison Between Liver Peritoneal Implants Versus Intrahepatic Metastases - Simone Famularo

Q&A 

Moderators: Concepción Gómez-Gavara & Fernando Rotellar

• Robotic Liver Resection With Versus Without Common Bile Duct Resection For Gallbladder Cancer: A Multicentric International Propensity Score-Matched Comparative Analysis - Giuseppe Esposito
• Improved Short-Term Outcomes with Fully Robotic Recipient Adult Living Donor Liver Transplantation: A Comparative Study - Dieter Broering
• Machine Learning-Based risk assessment for Postoperative Bile Leakage After Liver Resection - Simone Conci
• AI-Driven Markerless Augmented Reality Navigation for Enhanced Spatial Recognition in Liver Surgery - Maki Sugimoto
• Outcomes Of Robotic Versus Open Liver Resection With Common Bile Duct Resection For Gallbladder Cancer: An International Multi-Institutional Propensity Score-Matched Study - Giuseppe Esposito

Q&A

Moderators: Nicolas Goldaracena & Alejandro Serrablo

• Role of systemic chemotherapy - Erica Tsang
• Role of Molecular Profile and ct-DNA - Enrique Sanz Garcia
• Role of locoregional treatments including Hepatic Artery Infusion Pump (HAIP) - Paul Karanicolas
• Role of surgical resection including management of missing metastases - Lucas McCormack
• Role of liver transplantation - Roberto Hernandez-Alejandro

Q&A

Welcome and Introductory Remarks by Gonzalo Sapisochin, Nazia Selzner & Cythina Tsien

Joint ISLS & DEI in Transplant Session: Enabling Exemplary Care Through Behavioural Empathy 

Speaker: Nouman Ashraf